- GLP
About
Genevoyager provides AAV, vaccine, in vivo CAR-T, protein, pseudovirus, lentiviral, oncolytic virus, cell line, stem cell, and disease model services. It serves biopharma and research clients with CRO, CDMO, and technology-platform offerings in gene therapy and related biologics work.
Services
AAV CDMO
CDMO services for AAV development and manufacturing.
CDMO: development & manufacturing
Prophylatic/Therapeutic Vaccine Proprietary Technology
Proprietary technology for prophylactic and therapeutic vaccine work, including cell banking, virus banking, process development, analytical method development, and quality control.
CDMO: development & manufacturing
Lentiviral Vector-Mediated In Vivo CAR-T CRO/CDMO
CRO/CDMO services for lentiviral vector-mediated in vivo CAR-T with proprietary vector platform, molecular design, manufacturing, and analytics.
AAV Drug Screening
Screening service for AAV-related drug evaluation.
Assays & in vitro testing
Kinase Drug Screening
Screening service for kinase-targeted drug evaluation.
Assays & in vitro testing
Pharmacodynamic Evaluation
Pharmacodynamic evaluation services for drug candidates.
ADME, DMPK & toxicology
Pharmacokinetic Studies
Pharmacokinetic study services for drug candidates.
ADME, DMPK & toxicology
Non-GLP Nonclinical Safety Evaluation
Non-GLP nonclinical safety evaluation services.
ADME, DMPK & toxicology
AAV Neutralizing Antibody Assay
Neutralizing antibody assay services for AAV programs.
Assays & in vitro testing
Protein Expression
Protein expression services.
Protein production
Polypeptide Expression
Polypeptide expression services.
Protein production
Virus-like Particles (VLPs)
Virus-like particle production services.
Protein production
Lentiviral Packaging Service
Lentiviral packaging services.
Protein production
Oncolytic Viruses Service
Services for herpes simplex virus, vaccinia virus, adenovirus, reovirus, and vesicular stomatitis virus.
Cell Line Construction
Cell line construction services.
Gene-Modified Mesenchymal Stem Cell (MSC)
Stem cell services for gene-modified mesenchymal stem cells.
In Vitro Diagnostic Raw Materials
Raw materials for in vitro diagnostics, including autoimmune disease detection and pseudovirus products.
Neutralizing Antibody Assays
Neutralizing antibody assay products and services.
Assays & in vitro testing
One-Bac 4.0 System
A proprietary technology platform named One-Bac 4.0 System.
Molecular Cloning and Screening Platform
A molecular cloning and screening technology platform.
Animal Disease Model Construction Platform
A platform for constructing animal disease models.
Neutralizing Antibody Detection Platform
A platform for detecting neutralizing antibodies.
Assays & in vitro testing
Thyroperoxidase (TPO) — Diagnostic Raw Materials for GMP
Protein products for diagnostic raw materials for GMP use.
Protein production
AAV Products
AAV product offerings including AAV-1.3×HBV, AAV-1.2×HDV, Alzheimer’s disease (AD) model AAV, and AAV-PCSK9 atherosclerosis model.
Proprietary Technology for AAV / Vaccine / in vivo CAR-T CDMO
Offers process development, analytical method development and quality control, and cell/bacteria/virus banking support.
Innovative Drug Non-clinical Evaluation CRO Service
Provides one-stop non-clinical evaluation services for innovative drugs.
ADME, DMPK & toxicology
Directed Evolution of AAV CRO Service
Provides CRO support for directed evolution of AAV.
Assays & in vitro testing
Protein and VLP Service
Provides protein expression, polypeptide expression, and virus-like particle production services.
Protein production
Cell Line Construction Services
Provides cell line construction services.
Stem Cell Service
Provides gene-modified mesenchymal stem cell services.
Capabilities
- Assays and studies
- AAV · Lentivirus · In vivo · Antibodies · Cell therapy · Analytical development · PK/PD · Process development · Peptides · AAV neutralizing antibody assay · Neutralizing antibody assays · Neutralizing antibody detection
5 more
AAV drug screening · Kinase drug screening · Pharmacodynamic evaluation · Drug screening · Pharmacokinetic studies - Therapeutic areas
- Gene therapy · Vaccines · Alzheimer’s disease · Atherosclerosis · Autoimmune disease · Infectious disease
Modalities and species
- Modalities
- Antibody · Peptide · Viral vector · Cell therapy · Vaccine
- Species and models
- Alzheimer’s Disease (AD) model · AAV-PCSK9 atherosclerosis model · AAV-1.3×HBV · AAV-1.2×HDV · Mesenchymal stem cell (MSC) · One-Bac 4.0 System
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
GLPSelf-reported
ISO 9001Self-reported
Industries served
- Biotech
Company
- Type
- CRDMO
- Founded
- 2014
Locations
- Address
- 3675 Market Street, Suite 200, Philadelphia, PA 19104
Similar labs
Work here? Claim this listing